Industry Research Reports

Home > Reports > Chemical & Material > Global Isoprinosine Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

Global Isoprinosine Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

Industry: Chemical & Material

Published Date: 2025-09-10

Pages: 99 Pages

Report ld: 4932024

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Isoprinosine Market Size(US$)

CAGR 2025-2031

3.8%

Market Size,2031

USD 322

Million

Market Snapshot

Market Size in 2025 (Value)

US$ 258 million

Market Forecast in 2031(Value)

US$ 322 million

CAGR

3.8%

Years Considered

2020-2031

Base Year

2025

Forecast Period

2025-2031

Source: Secondary research, interviews with experts, and QYResearch analysis

The global Isoprinosine market size was US$ 249 million in 2024 and is forecast to a readjusted size of US$ 322 million by 2031 with a CAGR of 3.8% during the forecast period 2025-2031.

By 2025, the evolving U.S. tariff policy is poised to inject considerable uncertainty into the global economic landscape. This report delves into the latest U.S. tariff measures and the corresponding policy responses across the globe, evaluating their impacts on Isoprinosine market competitiveness, regional economic performance, and supply chain configurations.

Isoprinosine is an antiviral drug that is a combination of inosine and dimepranol acedoben (a salt of acetamidobenzoic acid and dimethylaminoisopropanol) in a ratio of 1 to 3. It is used for its immunomodulatory properties and is believed to enhance the body"s immune response. Isoprinosine is used in the treatment of various viral infections and immune-related disorders, although its exact mechanisms of action are not fully understood.

Isoprinosine has been used in SSPE, herpes simplex virus, human papillomavirus, HIV, influenza virus, and airway virus infections, cytomegalovirus, and Epstein-Barr virus infections.

In our report, for the tablet, one unit is 20 tablets in one box. For the syrup, one unit is one bottle.

Global key players of Isoprinosine include Newport Pharmaceuticals, Gedeon Richter, Sanofi, etc. The top three players hold a share over 60%.

Europe is the largest market, has a share about 63%, followed by Middle East, Africa and Latin America, with share18%.

In terms of product type, tablet is the largest segment, occupied for a share of 91%, and in terms of application, pharmacy has a share about 51 percent.

The global Isoprinosine market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2020-2031.

MARKET SEGMENTATION

By Company

Newport Pharmaceuticals
Gedeon Richter
Mochida
Sanofi
Andrómaco
Yung Shin
Alfasigma SpA
Polfarmex
Sanfer
Meprofarm
Novell Pharmaceutical
Aflofarm
KoRa Healthcare

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Tablet
Syrup

Segment by Application

Hospital & Clinic
Pharmacy
Other

biaoTi CHAPTER OUTLINE

Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).

Chapter 2: Quantitative analysis of Isoprinosine market size and growth potential at global, regional, and country levels.

Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).

Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Syrup in China).

Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Pharmacy in India).

Chapter 6: Regional sales and revenue breakdown by company, type, application and customer.

Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.

Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.

Chapter 9: Actionable conclusions and strategic recommendations.

WHY THIS REPORT

Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Isoprinosine value chain, addressing:

- Market entry risks/opportunities by region

- Product mix optimization based on local practices

- Competitor tactics in fragmented vs. consolidated markets

biaoTi QYRESEARCH'S STRENGTHS

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Market Overview

1.1 Isoprinosine Product Scope

1.2 Isoprinosine by Type

1.2.1 Global Isoprinosine Sales by Type (2020 & 2024 & 2031)

1.2.2 Tablet

1.2.3 Syrup

1.3 Isoprinosine by Application

1.3.1 Global Isoprinosine Sales Comparison by Application (2020 & 2024 & 2031)

1.3.2 Hospital & Clinic

1.3.3 Pharmacy

1.3.4 Other

1.4 Global Isoprinosine Market Estimates and Forecasts (2020-2031)

1.4.1 Global Isoprinosine Market Size in Value Growth Rate (2020-2031)

1.4.2 Global Isoprinosine Market Size in Volume Growth Rate (2020-2031)

1.4.3 Global Isoprinosine Price Trends (2020-2031)

1.5 Assumptions and Limitations

2 Market Size and Prospective by Region

2.1 Global Isoprinosine Market Size by Region: 2020 VS 2024 VS 2031

2.2 Global Isoprinosine Retrospective Market Scenario by Region (2020-2025)

2.2.1 Global Isoprinosine Sales Market Share by Region (2020-2025)

2.2.2 Global Isoprinosine Revenue Market Share by Region (2020-2025)

2.3 Global Isoprinosine Market Estimates and Forecasts by Region (2026-2031)

2.3.1 Global Isoprinosine Sales Estimates and Forecasts by Region (2026-2031)

2.3.2 Global Isoprinosine Revenue Forecast by Region (2026-2031)

2.4 Major Region and Emerging Market Analysis

2.4.1 Indonesia Isoprinosine Market Size and Prospective (2020-2031)

2.4.2 Europe Isoprinosine Market Size and Prospective (2020-2031)

2.4.3 China Taiwan Isoprinosine Market Size and Prospective (2020-2031)

2.4.4 Japan Isoprinosine Market Size and Prospective (2020-2031)

2.4.5 South America Isoprinosine Market Size and Prospective (2020-2031)

3 Global Market Size by Type

3.1 Global Isoprinosine Historic Market Review by Type (2020-2025)

3.1.1 Global Isoprinosine Sales by Type (2020-2025)

3.1.2 Global Isoprinosine Revenue by Type (2020-2025)

3.1.3 Global Isoprinosine Price by Type (2020-2025)

3.2 Global Isoprinosine Market Estimates and Forecasts by Type (2026-2031)

3.2.1 Global Isoprinosine Sales Forecast by Type (2026-2031)

3.2.2 Global Isoprinosine Revenue Forecast by Type (2026-2031)

3.2.3 Global Isoprinosine Price Forecast by Type (2026-2031)

3.3 Different Types Isoprinosine Representative Players

4 Global Market Size by Application

4.1 Global Isoprinosine Historic Market Review by Application (2020-2025)

4.1.1 Global Isoprinosine Sales by Application (2020-2025)

4.1.2 Global Isoprinosine Revenue by Application (2020-2025)

4.1.3 Global Isoprinosine Price by Application (2020-2025)

4.2 Global Isoprinosine Market Estimates and Forecasts by Application (2026-2031)

4.2.1 Global Isoprinosine Sales Forecast by Application (2026-2031)

4.2.2 Global Isoprinosine Revenue Forecast by Application (2026-2031)

4.2.3 Global Isoprinosine Price Forecast by Application (2026-2031)

4.3 New Sources of Growth in Isoprinosine Application

5 Competition Landscape by Players

5.1 Global Isoprinosine Sales by Players (2020-2025)

5.2 Global Top Isoprinosine Players by Revenue (2020-2025)

5.3 Global Isoprinosine Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Isoprinosine as of 2024)

5.4 Global Isoprinosine Average Price by Company (2020-2025)

5.5 Global Key Manufacturers of Isoprinosine, Manufacturing Sites & Headquarters

5.6 Global Key Manufacturers of Isoprinosine, Product Type & Application

5.7 Global Key Manufacturers of Isoprinosine, Date of Enter into This Industry

5.8 Manufacturers Mergers & Acquisitions, Expansion Plans

6 Region Analysis

6.1 Indonesia Market: Players, Segments, Downstream and Major Customers

6.1.1 Indonesia Isoprinosine Sales by Company

6.1.1.1 Indonesia Isoprinosine Sales by Company (2020-2025)

6.1.1.2 Indonesia Isoprinosine Revenue by Company (2020-2025)

6.1.2 Indonesia Isoprinosine Sales Breakdown by Type (2020-2025)

6.1.3 Indonesia Isoprinosine Sales Breakdown by Application (2020-2025)

6.1.4 Indonesia Isoprinosine Major Customer

6.1.5 Indonesia Market Trend and Opportunities

6.2 Europe Market: Players, Segments, Downstream and Major Customers

6.2.1 Europe Isoprinosine Sales by Company

6.2.1.1 Europe Isoprinosine Sales by Company (2020-2025)

6.2.1.2 Europe Isoprinosine Revenue by Company (2020-2025)

6.2.2 Europe Isoprinosine Sales Breakdown by Type (2020-2025)

6.2.3 Europe Isoprinosine Sales Breakdown by Application (2020-2025)

6.2.4 Europe Isoprinosine Major Customer

6.2.5 Europe Market Trend and Opportunities

6.3 China Taiwan Market: Players, Segments, Downstream and Major Customers

6.3.1 China Taiwan Isoprinosine Sales by Company

6.3.1.1 China Taiwan Isoprinosine Sales by Company (2020-2025)

6.3.1.2 China Taiwan Isoprinosine Revenue by Company (2020-2025)

6.3.2 China Taiwan Isoprinosine Sales Breakdown by Type (2020-2025)

6.3.3 China Taiwan Isoprinosine Sales Breakdown by Application (2020-2025)

6.3.4 China Taiwan Isoprinosine Major Customer

6.3.5 China Taiwan Market Trend and Opportunities

6.4 Japan Market: Players, Segments, Downstream and Major Customers

6.4.1 Japan Isoprinosine Sales by Company

6.4.1.1 Japan Isoprinosine Sales by Company (2020-2025)

6.4.1.2 Japan Isoprinosine Revenue by Company (2020-2025)

6.4.2 Japan Isoprinosine Sales Breakdown by Type (2020-2025)

6.4.3 Japan Isoprinosine Sales Breakdown by Application (2020-2025)

6.4.4 Japan Isoprinosine Major Customer

6.4.5 Japan Market Trend and Opportunities

6.5 South America Market: Players, Segments, Downstream and Major Customers

6.5.1 South America Isoprinosine Sales by Company

6.5.1.1 South America Isoprinosine Sales by Company (2020-2025)

6.5.1.2 South America Isoprinosine Revenue by Company (2020-2025)

6.5.2 South America Isoprinosine Sales Breakdown by Type (2020-2025)

6.5.3 South America Isoprinosine Sales Breakdown by Application (2020-2025)

6.5.4 South America Isoprinosine Major Customer

6.5.5 South America Market Trend and Opportunities

7 Company Profiles and Key Figures

7.1 Newport Pharmaceuticals

7.1.1 Newport Pharmaceuticals Company Information

7.1.2 Newport Pharmaceuticals Business Overview

7.1.3 Newport Pharmaceuticals Isoprinosine Sales, Revenue and Gross Margin (2020-2025)

7.1.4 Newport Pharmaceuticals Isoprinosine Products Offered

7.1.5 Newport Pharmaceuticals Recent Development

7.2 Gedeon Richter

7.2.1 Gedeon Richter Company Information

7.2.2 Gedeon Richter Business Overview

7.2.3 Gedeon Richter Isoprinosine Sales, Revenue and Gross Margin (2020-2025)

7.2.4 Gedeon Richter Isoprinosine Products Offered

7.2.5 Gedeon Richter Recent Development

7.3 Mochida

7.3.1 Mochida Company Information

7.3.2 Mochida Business Overview

7.3.3 Mochida Isoprinosine Sales, Revenue and Gross Margin (2020-2025)

7.3.4 Mochida Isoprinosine Products Offered

7.3.5 Mochida Recent Development

7.4 Sanofi

7.4.1 Sanofi Company Information

7.4.2 Sanofi Business Overview

7.4.3 Sanofi Isoprinosine Sales, Revenue and Gross Margin (2020-2025)

7.4.4 Sanofi Isoprinosine Products Offered

7.4.5 Sanofi Recent Development

7.5 Andrómaco

7.5.1 Andrómaco Company Information

7.5.2 Andrómaco Business Overview

7.5.3 Andrómaco Isoprinosine Sales, Revenue and Gross Margin (2020-2025)

7.5.4 Andrómaco Isoprinosine Products Offered

7.5.5 Andrómaco Recent Development

7.6 Yung Shin

7.6.1 Yung Shin Company Information

7.6.2 Yung Shin Business Overview

7.6.3 Yung Shin Isoprinosine Sales, Revenue and Gross Margin (2020-2025)

7.6.4 Yung Shin Isoprinosine Products Offered

7.6.5 Yung Shin Recent Development

7.7 Alfasigma SpA

7.7.1 Alfasigma SpA Company Information

7.7.2 Alfasigma SpA Business Overview

7.7.3 Alfasigma SpA Isoprinosine Sales, Revenue and Gross Margin (2020-2025)

7.7.4 Alfasigma SpA Isoprinosine Products Offered

7.7.5 Alfasigma SpA Recent Development

7.8 Polfarmex

7.8.1 Polfarmex Company Information

7.8.2 Polfarmex Business Overview

7.8.3 Polfarmex Isoprinosine Sales, Revenue and Gross Margin (2020-2025)

7.8.4 Polfarmex Isoprinosine Products Offered

7.8.5 Polfarmex Recent Development

7.9 Sanfer

7.9.1 Sanfer Company Information

7.9.2 Sanfer Business Overview

7.9.3 Sanfer Isoprinosine Sales, Revenue and Gross Margin (2020-2025)

7.9.4 Sanfer Isoprinosine Products Offered

7.9.5 Sanfer Recent Development

7.10 Meprofarm

7.10.1 Meprofarm Company Information

7.10.2 Meprofarm Business Overview

7.10.3 Meprofarm Isoprinosine Sales, Revenue and Gross Margin (2020-2025)

7.10.4 Meprofarm Isoprinosine Products Offered

7.10.5 Meprofarm Recent Development

7.11 Novell Pharmaceutical

7.11.1 Novell Pharmaceutical Company Information

7.11.2 Novell Pharmaceutical Business Overview

7.11.3 Novell Pharmaceutical Isoprinosine Sales, Revenue and Gross Margin (2020-2025)

7.11.4 Novell Pharmaceutical Isoprinosine Products Offered

7.11.5 Novell Pharmaceutical Recent Development

7.12 Aflofarm

7.12.1 Aflofarm Company Information

7.12.2 Aflofarm Business Overview

7.12.3 Aflofarm Isoprinosine Sales, Revenue and Gross Margin (2020-2025)

7.12.4 Aflofarm Isoprinosine Products Offered

7.12.5 Aflofarm Recent Development

7.13 KoRa Healthcare

7.13.1 KoRa Healthcare Company Information

7.13.2 KoRa Healthcare Business Overview

7.13.3 KoRa Healthcare Isoprinosine Sales, Revenue and Gross Margin (2020-2025)

7.13.4 KoRa Healthcare Isoprinosine Products Offered

7.13.5 KoRa Healthcare Recent Development

8 Isoprinosine Manufacturing Cost Analysis

8.1 Isoprinosine Key Raw Materials Analysis

8.1.1 Key Raw Materials

8.1.2 Key Suppliers of Raw Materials

8.2 Proportion of Manufacturing Cost Structure

8.3 Manufacturing Process Analysis of Isoprinosine

8.4 Isoprinosine Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers

9.1 Marketing Channel

9.2 Isoprinosine Distributors List

9.3 Isoprinosine Customers

10 Isoprinosine Market Dynamics

10.1 Isoprinosine Industry Trends

10.2 Isoprinosine Market Drivers

10.3 Isoprinosine Market Challenges

10.4 Isoprinosine Market Restraints

11 Research Findings and Conclusion

12 Appendix

12.1 Research Methodology

12.1.1 Methodology/Research Approach

12.1.1.1 Research Programs/Design

12.1.1.2 Market Size Estimation

12.1.1.3 Market Breakdown and Data Triangulation

12.1.2 Data Source

12.1.2.1 Secondary Sources

12.1.2.2 Primary Sources

12.2 Author Details

12.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Global Isoprinosine Sales (US$ Million) Growth Rate by Type (2020 & 2024 & 2031)

Table 2. Global Isoprinosine Sales (US$ Million) Comparison by Application (2020 & 2024 & 2031)

Table 3. Global Market Isoprinosine Market Size (US$ Million) by Region:2020 VS 2024 VS 2031

Table 4. Global Isoprinosine Sales (K Units) by Region (2020-2025)

Table 5. Global Isoprinosine Sales Market Share by Region (2020-2025)

Table 6. Global Isoprinosine Revenue (US$ Million) Market Share by Region (2020-2025)

Table 7. Global Isoprinosine Revenue Share by Region (2020-2025)

Table 8. Global Isoprinosine Sales (K Units) Forecast by Region (2026-2031)

Table 9. Global Isoprinosine Sales Market Share Forecast by Region (2026-2031)

Table 10. Global Isoprinosine Revenue (US$ Million) Forecast by Region (2026-2031)

Table 11. Global Isoprinosine Revenue Share Forecast by Region (2026-2031)

Table 12. Global Isoprinosine Sales by Type (K Units) & (2020-2025)

Table 13. Global Isoprinosine Sales Share by Type (2020-2025)

Table 14. Global Isoprinosine Revenue by Type (US$ Million) & (2020-2025)

Table 15. Global Isoprinosine Price by Type (US$/Unit) & (2020-2025)

Table 16. Global Isoprinosine Sales by Type (K Units) & (2026-2031)

Table 17. Global Isoprinosine Revenue by Type (US$ Million) & (2026-2031)

Table 18. Global Isoprinosine Price by Type (US$/Unit) & (2026-2031)

Table 19. Representative Players of Each Type

Table 20. Global Isoprinosine Sales by Application (K Units) & (2020-2025)

Table 21. Global Isoprinosine Sales Share by Application (2020-2025)

Table 22. Global Isoprinosine Revenue by Application (US$ Million) & (2020-2025)

Table 23. Global Isoprinosine Price by Application (US$/Unit) & (2020-2025)

Table 24. Global Isoprinosine Sales by Application (K Units) & (2026-2031)

Table 25. Global Isoprinosine Revenue Market Share by Application (US$ Million) & (2026-2031)

Table 26. Global Isoprinosine Price by Application (US$/Unit) & (2026-2031)

Table 27. New Sources of Growth in Isoprinosine Application

Table 28. Global Isoprinosine Sales by Company (K Units) & (2020-2025)

Table 29. Global Isoprinosine Sales Share by Company (2020-2025)

Table 30. Global Isoprinosine Revenue by Company (US$ Million) & (2020-2025)

Table 31. Global Isoprinosine Revenue Share by Company (2020-2025)

Table 32. Global Isoprinosine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Isoprinosine as of 2024)

Table 33. Global Market Isoprinosine Average Price by Company (US$/Unit) & (2020-2025)

Table 34. Global Key Manufacturers of Isoprinosine, Manufacturing Sites & Headquarters

Table 35. Global Key Manufacturers of Isoprinosine, Product Type & Application

Table 36. Global Key Manufacturers of Isoprinosine, Date of Enter into This Industry

Table 37. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 38. Indonesia Isoprinosine Sales by Company (2020-2025) & (K Units)

Table 39. Indonesia Isoprinosine Sales Market Share by Company (2020-2025)

Table 40. Indonesia Isoprinosine Revenue by Company (2020-2025) & (US$ Million)

Table 41. Indonesia Isoprinosine Revenue Market Share by Company (2020-2025)

Table 42. Indonesia Isoprinosine Sales by Type (2020-2025) & (K Units)

Table 43. Indonesia Isoprinosine Sales Market Share by Type (2020-2025)

Table 44. Indonesia Isoprinosine Sales by Application (2020-2025) & (K Units)

Table 45. Indonesia Isoprinosine Sales Market Share by Application (2020-2025)

Table 46. Europe Isoprinosine Sales by Company (2020-2025) & (K Units)

Table 47. Europe Isoprinosine Sales Market Share by Company (2020-2025)

Table 48. Europe Isoprinosine Revenue by Company (2020-2025) & (US$ Million)

Table 49. Europe Isoprinosine Revenue Market Share by Company (2020-2025)

Table 50. Europe Isoprinosine Sales by Type (2020-2025) & (K Units)

Table 51. Europe Isoprinosine Sales Market Share by Type (2020-2025)

Table 52. Europe Isoprinosine Sales by Application (2020-2025) & (K Units)

Table 53. Europe Isoprinosine Sales Market Share by Application (2020-2025)

Table 54. China Taiwan Isoprinosine Sales by Company (2020-2025) & (K Units)

Table 55. China Taiwan Isoprinosine Sales Market Share by Company (2020-2025)

Table 56. China Taiwan Isoprinosine Revenue by Company (2020-2025) & (US$ Million)

Table 57. China Taiwan Isoprinosine Revenue Market Share by Company (2020-2025)

Table 58. China Taiwan Isoprinosine Sales by Type (2020-2025) & (K Units)

Table 59. China Taiwan Isoprinosine Sales Market Share by Type (2020-2025)

Table 60. China Taiwan Isoprinosine Sales by Application (2020-2025) & (K Units)

Table 61. China Taiwan Isoprinosine Sales Market Share by Application (2020-2025)

Table 62. Japan Isoprinosine Sales by Company (2020-2025) & (K Units)

Table 63. Japan Isoprinosine Sales Market Share by Company (2020-2025)

Table 64. Japan Isoprinosine Revenue by Company (2020-2025) & (US$ Million)

Table 65. Japan Isoprinosine Revenue Market Share by Company (2020-2025)

Table 66. Japan Isoprinosine Sales by Type (2020-2025) & (K Units)

Table 67. Japan Isoprinosine Sales Market Share by Type (2020-2025)

Table 68. Japan Isoprinosine Sales by Application (2020-2025) & (K Units)

Table 69. Japan Isoprinosine Sales Market Share by Application (2020-2025)

Table 70. South America Isoprinosine Sales by Company (2020-2025) & (K Units)

Table 71. South America Isoprinosine Sales Market Share by Company (2020-2025)

Table 72. South America Isoprinosine Revenue by Company (2020-2025) & (US$ Million)

Table 73. South America Isoprinosine Revenue Market Share by Company (2020-2025)

Table 74. South America Isoprinosine Sales by Type (2020-2025) & (K Units)

Table 75. South America Isoprinosine Sales Market Share by Type (2020-2025)

Table 76. South America Isoprinosine Sales by Application (2020-2025) & (K Units)

Table 77. South America Isoprinosine Sales Market Share by Application (2020-2025)

Table 78. Newport Pharmaceuticals Company Information

Table 79. Newport Pharmaceuticals Description and Business Overview

Table 80. Newport Pharmaceuticals Isoprinosine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 81. Newport Pharmaceuticals Isoprinosine Product

Table 82. Newport Pharmaceuticals Recent Development

Table 83. Gedeon Richter Company Information

Table 84. Gedeon Richter Description and Business Overview

Table 85. Gedeon Richter Isoprinosine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 86. Gedeon Richter Isoprinosine Product

Table 87. Gedeon Richter Recent Development

Table 88. Mochida Company Information

Table 89. Mochida Description and Business Overview

Table 90. Mochida Isoprinosine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 91. Mochida Isoprinosine Product

Table 92. Mochida Recent Development

Table 93. Sanofi Company Information

Table 94. Sanofi Description and Business Overview

Table 95. Sanofi Isoprinosine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 96. Sanofi Isoprinosine Product

Table 97. Sanofi Recent Development

Table 98. Andrómaco Company Information

Table 99. Andrómaco Description and Business Overview

Table 100. Andrómaco Isoprinosine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 101. Andrómaco Isoprinosine Product

Table 102. Andrómaco Recent Development

Table 103. Yung Shin Company Information

Table 104. Yung Shin Description and Business Overview

Table 105. Yung Shin Isoprinosine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 106. Yung Shin Isoprinosine Product

Table 107. Yung Shin Recent Development

Table 108. Alfasigma SpA Company Information

Table 109. Alfasigma SpA Description and Business Overview

Table 110. Alfasigma SpA Isoprinosine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 111. Alfasigma SpA Isoprinosine Product

Table 112. Alfasigma SpA Recent Development

Table 113. Polfarmex Company Information

Table 114. Polfarmex Description and Business Overview

Table 115. Polfarmex Isoprinosine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 116. Polfarmex Isoprinosine Product

Table 117. Polfarmex Recent Development

Table 118. Sanfer Company Information

Table 119. Sanfer Description and Business Overview

Table 120. Sanfer Isoprinosine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 121. Sanfer Isoprinosine Product

Table 122. Sanfer Recent Development

Table 123. Meprofarm Company Information

Table 124. Meprofarm Description and Business Overview

Table 125. Meprofarm Isoprinosine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 126. Meprofarm Isoprinosine Product

Table 127. Meprofarm Recent Development

Table 128. Novell Pharmaceutical Company Information

Table 129. Novell Pharmaceutical Description and Business Overview

Table 130. Novell Pharmaceutical Isoprinosine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 131. Novell Pharmaceutical Isoprinosine Product

Table 132. Novell Pharmaceutical Recent Development

Table 133. Aflofarm Company Information

Table 134. Aflofarm Description and Business Overview

Table 135. Aflofarm Isoprinosine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 136. Aflofarm Isoprinosine Product

Table 137. Aflofarm Recent Development

Table 138. KoRa Healthcare Company Information

Table 139. KoRa Healthcare Description and Business Overview

Table 140. KoRa Healthcare Isoprinosine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 141. KoRa Healthcare Isoprinosine Product

Table 142. KoRa Healthcare Recent Development

Table 143. Production Base and Market Concentration Rate of Raw Material

Table 144. Key Suppliers of Raw Materials

Table 145. Isoprinosine Distributors List

Table 146. Isoprinosine Customers List

Table 147. Isoprinosine Market Trends

Table 148. Isoprinosine Market Drivers

Table 149. Isoprinosine Market Challenges

Table 150. Isoprinosine Market Restraints

Table 151. Research Programs/Design for This Report

Table 152. Key Data Information from Secondary Sources

Table 153. Key Data Information from Primary Sources

List of Figures

Figure 1. Isoprinosine Product Picture

Figure 2. Global Isoprinosine Sales (US$ Million) by Type (2020 & 2024 & 2031)

Figure 3. Global Isoprinosine Sales Market Share by Type in 2024 & 2031

Figure 4. Tablet Product Picture

Figure 5. Syrup Product Picture

Figure 6. Global Isoprinosine Sales (US$ Million) by Application (2020 & 2024 & 2031)

Figure 7. Global Isoprinosine Sales Market Share by Application in 2024 & 2031

Figure 8. Hospital & Clinic Examples

Figure 9. Pharmacy Examples

Figure 10. Other Examples

Figure 11. Global Isoprinosine Sales, (US$ Million), 2020 VS 2024 VS 2031

Figure 12. Global Isoprinosine Sales Growth Rate (2020-2031) & (US$ Million)

Figure 13. Global Isoprinosine Sales (K Units) Growth Rate (2020-2031)

Figure 14. Global Isoprinosine Price Trends Growth Rate (2020-2031) & (US$/Unit)

Figure 15. Isoprinosine Report Years Considered

Figure 16. Global Market Isoprinosine Market Size (US$ Million) by Region:2020 VS 2024 VS 2031

Figure 17. Global Isoprinosine Revenue Market Share by Region: 2020 VS 2024

Figure 18. Indonesia Isoprinosine Revenue (US$ Million) Growth Rate (2020-2031)

Figure 19. Indonesia Isoprinosine Sales (K Units) Growth Rate (2020-2031)

Figure 20. Europe Isoprinosine Revenue (US$ Million) Growth Rate (2020-2031)

Figure 21. Europe Isoprinosine Sales (K Units) Growth Rate (2020-2031)

Figure 22. China Taiwan Isoprinosine Revenue (US$ Million) Growth Rate (2020-2031)

Figure 23. China Taiwan Isoprinosine Sales (K Units) Growth Rate (2020-2031)

Figure 24. Japan Isoprinosine Revenue (US$ Million) Growth Rate (2020-2031)

Figure 25. Japan Isoprinosine Sales (K Units) Growth Rate (2020-2031)

Figure 26. South America Isoprinosine Revenue (US$ Million) Growth Rate (2020-2031)

Figure 27. South America Isoprinosine Sales (K Units) Growth Rate (2020-2031)

Figure 28. Global Isoprinosine Revenue Share by Type (2020-2025)

Figure 29. Global Isoprinosine Sales Share by Type (2026-2031)

Figure 30. Global Isoprinosine Revenue Share by Type (2026-2031)

Figure 31. Global Isoprinosine Revenue Share by Application (2020-2025)

Figure 32. Global Isoprinosine Revenue Growth Rate by Application in 2020 & 2024

Figure 33. Global Isoprinosine Sales Share by Application (2026-2031)

Figure 34. Global Isoprinosine Revenue Share by Application (2026-2031)

Figure 35. Global Isoprinosine Sales Share by Company (2024)

Figure 36. Global Isoprinosine Revenue Share by Company (2024)

Figure 37. Global 5 Largest Isoprinosine Players Market Share by Revenue in Isoprinosine: 2020 & 2024

Figure 38. Isoprinosine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 39. Manufacturing Cost Structure of Isoprinosine

Figure 40. Manufacturing Process Analysis of Isoprinosine

Figure 41. Isoprinosine Industrial Chain

Figure 42. Channels of Distribution (Direct Vs Distribution)

Figure 43. Distributors Profiles

Figure 44. Bottom-up and Top-down Approaches for This Report

Figure 45. Data Triangulation

Figure 46. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Isoprinosine market? zhanKai

The top companies in the global Isoprinosine market are Newport Pharmaceuticals、Gedeon Richter、Mochida.

What was the global market size of Isoprinosine in 2025? shouQi

What is the annual compound growth rate of the global Isoprinosine market size from 2025 to 2031? shouQi

Which region is expected to have the highest market share? shouQi

What was the global market size of Isoprinosine in 2031? shouQi

Related Reports

Global Isoprinosine Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Isoprinosine market size was US$ 259 million in 2025 and is forecast to reach a readjusted size of US$ 336 million by 2032 with a CAGR of 3.8% during the forecast period 2026-2032.
Published Date: 2026-01-05
Pages: 98
USD 4250.00
(Single User License)
Global Isoprinosine Market Research Report 2026
The global Isoprinosine market was valued at US$ 259 million in 2025 and is anticipated to reach US$ 336 million by 2032, at a CAGR of 3.8% from 2026 to 2032.
Published Date: 2026-01-05
Pages: 138
USD 2900.00
(Single User License)
Isoprinosine- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Isoprinosine was estimated to be worth US$ 259 million in 2025 and is projected to reach US$ 336 million, growing at a CAGR of 3.8% from 2026 to 2032.
Published Date: 2026-01-05
Pages: 114
USD 3950.00
(Single User License)
Global Isoprinosine Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Isoprinosine market is projected to grow from US$ 249 million in 2024 to US$ 322 million by 2031, at a CAGR of 3.8% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-07-31
Pages: 166
USD 4900.00
(Single User License)
Isoprinosine- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Isoprinosine was estimated to be worth US$ 249 million in 2024 and is forecast to a readjusted size of US$ 322 million by 2031 with a CAGR of 3.8% during the forecast period 2025-2031.
Published Date: 2025-01-19
Pages: 126
USD 3950.00
(Single User License)
Global Isoprinosine Market Research Report 2025
The global market for Isoprinosine was valued at US$ 249 million in the year 2024 and is projected to reach a revised size of US$ 322 million by 2031, growing at a CAGR of 3.8% during the forecast period.
Published Date: 2025-01-19
Pages: 104
USD 2900.00
(Single User License)
Global Isoprinosine Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Isoprinosine is an antiviral drug that is a combination of inosine and dimepranol acedoben (a salt of acetamidobenzoic acid and dimethylaminoisopropanol) in a ratio of 1 to 3. It is used for its immunomodulatory properties and is believed to enhance the body's immune response. Isoprinosine is used in the treatment of various viral infections and immune-related disorders, although its exact mechanisms of action are not fully understood.
Published Date: 2024-04-17
Pages: 162
USD 5600.00
(Single User License)
Global Isoprinosine Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Isoprinosine is an antiviral drug that is a combination of inosine and dimepranol acedoben (a salt of acetamidobenzoic acid and dimethylaminoisopropanol) in a ratio of 1 to 3. It is used for its immunomodulatory properties and is believed to enhance the body's immune response. Isoprinosine is used in the treatment of various viral infections and immune-related disorders, although its exact mechanisms of action are not fully understood.
Published Date: 2024-04-16
Pages: 150
USD 5900.00
(Single User License)
Global Isoprinosine Market Insights, Forecast to 2030
Isoprinosine is an antiviral drug that is a combination of inosine and dimepranol acedoben (a salt of acetamidobenzoic acid and dimethylaminoisopropanol) in a ratio of 1 to 3. It is used for its immunomodulatory properties and is believed to enhance the body's immune response. Isoprinosine is used in the treatment of various viral infections and immune-related disorders, although its exact mechanisms of action are not fully understood.
Published Date: 2024-04-07
Pages: 113
USD 4900.00
(Single User License)
Isoprinosine - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Isoprinosine is an antiviral drug that is a combination of inosine and dimepranol acedoben (a salt of acetamidobenzoic acid and dimethylaminoisopropanol) in a ratio of 1 to 3. It is used for its immunomodulatory properties and is believed to enhance the body's immune response. Isoprinosine is used in the treatment of various viral infections and immune-related disorders, although its exact mechanisms of action are not fully understood.
Published Date: 2024-01-18
Pages: 123
USD 3950.00
(Single User License)

Global Isoprinosine Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Isoprinosine market size was US$ 259 million in 2025 and is forecast to reach a readjusted size of US$ 336 million by 2032 with a CAGR of 3.8% during the forecast period 2026-2032.
Published: 2026-01-05
Pages: 98
USD 4250.00 (Single User License)
Global Isoprinosine Market Research Report 2026
The global Isoprinosine market was valued at US$ 259 million in 2025 and is anticipated to reach US$ 336 million by 2032, at a CAGR of 3.8% from 2026 to 2032.
Published: 2026-01-05
Pages: 138
USD 2900.00 (Single User License)
Isoprinosine- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Isoprinosine was estimated to be worth US$ 259 million in 2025 and is projected to reach US$ 336 million, growing at a CAGR of 3.8% from 2026 to 2032.
Published: 2026-01-05
Pages: 114
USD 3950.00 (Single User License)
Global Isoprinosine Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Isoprinosine market is projected to grow from US$ 249 million in 2024 to US$ 322 million by 2031, at a CAGR of 3.8% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-07-31
Pages: 166
USD 4900.00 (Single User License)
Isoprinosine- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Isoprinosine was estimated to be worth US$ 249 million in 2024 and is forecast to a readjusted size of US$ 322 million by 2031 with a CAGR of 3.8% during the forecast period 2025-2031.
Published: 2025-01-19
Pages: 126
USD 3950.00 (Single User License)
Global Isoprinosine Market Research Report 2025
The global market for Isoprinosine was valued at US$ 249 million in the year 2024 and is projected to reach a revised size of US$ 322 million by 2031, growing at a CAGR of 3.8% during the forecast period.
Published: 2025-01-19
Pages: 104
USD 2900.00 (Single User License)
Global Isoprinosine Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Isoprinosine is an antiviral drug that is a combination of inosine and dimepranol acedoben (a salt of acetamidobenzoic acid and dimethylaminoisopropanol) in a ratio of 1 to 3. It is used for its immunomodulatory properties and is believed to enhance the body's immune response. Isoprinosine is used in the treatment of various viral infections and immune-related disorders, although its exact mechanisms of action are not fully understood.
Published: 2024-04-17
Pages: 162
USD 5600.00 (Single User License)
Global Isoprinosine Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Isoprinosine is an antiviral drug that is a combination of inosine and dimepranol acedoben (a salt of acetamidobenzoic acid and dimethylaminoisopropanol) in a ratio of 1 to 3. It is used for its immunomodulatory properties and is believed to enhance the body's immune response. Isoprinosine is used in the treatment of various viral infections and immune-related disorders, although its exact mechanisms of action are not fully understood.
Published: 2024-04-16
Pages: 150
USD 5900.00 (Single User License)
Global Isoprinosine Market Insights, Forecast to 2030
Isoprinosine is an antiviral drug that is a combination of inosine and dimepranol acedoben (a salt of acetamidobenzoic acid and dimethylaminoisopropanol) in a ratio of 1 to 3. It is used for its immunomodulatory properties and is believed to enhance the body's immune response. Isoprinosine is used in the treatment of various viral infections and immune-related disorders, although its exact mechanisms of action are not fully understood.
Published: 2024-04-07
Pages: 113
USD 4900.00 (Single User License)
Isoprinosine - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Isoprinosine is an antiviral drug that is a combination of inosine and dimepranol acedoben (a salt of acetamidobenzoic acid and dimethylaminoisopropanol) in a ratio of 1 to 3. It is used for its immunomodulatory properties and is believed to enhance the body's immune response. Isoprinosine is used in the treatment of various viral infections and immune-related disorders, although its exact mechanisms of action are not fully understood.
Published: 2024-01-18
Pages: 123
USD 3950.00 (Single User License)